Psoriasis Vulgaris
📧 Sign up to get email alerts when something new happens for Psoriasis Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds [Phase 2]
Phase 2 clinical trial evaluating calcipotriol plus hydrocortisone ointment on adrenal hormone balance and calcium metabolism in psoriasis v…
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris [Phase 3]
Phase 3 trial update for LEO 90100 with a twice-weekly maintenance regimen in psoriasis vulgaris completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis). [Phase 3]
Phase 3 trial studying generic calcipotriene and betamethasone dipropionate topical foam for psoriasis vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis [Phase 2]
A Phase 2 clinical trial of PRCL-02 in moderate to severe chronic plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Formulation and Clinical Evaluation of Ethosomal and Liposomal Preparations of Anthralin in Psoriasis [Phase 4]
Phase 4 clinical trial evaluating ethosomal and liposomal formulations of anthralin for psoriasis vulgaris has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream [Phase 2]
Phase 2 trial update assessing PK profile of MC2-01 cream in psoriasis vulgaris completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products [Phase 2]
Phase 2 study of LEO 29102 Cream (and its combination products) for psoriasis vulgaris has been completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: A Phase 4 Clinical Study of Brodalumab [Phase 4]
A Phase 4 clinical study of brodalumab completed, investigating psoriasis vulgaris and psoriatic arthritis (with related pustular and erythr…
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis [Phase 4]
Phase 4 long-term safety and efficacy study of Calcitriol 3 mcg/g ointment in pediatric patients with plaque psoriasis has completed with re…
-
CLINICAL_TRIALS trial_result · 2019-05-23Clinical Trial Update: Oral Chinese Herbal Medicine for Psoriasis Vulgaris With Blood Heat Syndrome [Phase 2]
A Phase 2 clinical trial evaluating an oral Chinese herbal medicine for psoriasis vulgaris with blood heat syndrome is underway, with status…
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Oral Chinese Herbal Medicine for Psoriasis Vulgaris With Blood Stasis Syndrome [Phase 2]
Phase 2 clinical trial investigating an oral Chinese herbal medicine for psoriasis vulgaris with blood stasis syndrome.
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris [Phase 2]
A phase 2 trial evaluating the efficacy and safety of LEO 19123 cream for psoriasis vulgaris has completed, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-18Clinical Trial Update: Role of Topical Treatments in the Modulation of Skin Microbiome in Psoriatic Skin [Phase 2]
Phase 2 trial evaluating topical treatments for modulation of the skin microbiome in psoriatic skin (Psoriasis Vulgaris) completed.
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris [Phase 2]
Phase 2 trial of SNA-120 for pruritus in patients with psoriasis vulgaris; the update reports safety, efficacy, and tolerability findings.
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis [Phase 2]
Phase 2 trial assessing safety and efficacy of once-daily LEO 90100 aerosol foam in adolescents with plaque psoriasis; results completed and…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas [Phase 3]
Phase 3 trial comparing LEO 80190 ointment with hydrocortisone ointment, both applied once daily for psoriasis vulgaris on the face and inte…
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Efficacy and Safety of Blue Light (453 nm) Treatment for Mild Psoriasis Vulgaris Over Three Months Compared to Vitamin D. [NA]
A completed clinical trial evaluating efficacy and safety of blue light 453 nm treatment for mild psoriasis vulgaris over three months versu…
-
CLINICAL_TRIALS trial_result · 2018-11-06Clinical Trial Update: An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects [Phase 2]
A Phase 2, open-label, non-controlled, single-group trial in adolescents with psoriasis vulgaris completed, with results posted by LEO Pharm…
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris [Phase 2]
Phase 2 proof-of-concept trial comparing three doses of oral LEO 22811 to placebo in psoriasis vulgaris; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-22Clinical Trial Update: Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis [Phase 3]
Phase 3 trial assessing safety, tolerability, and efficacy of secukinumab in moderate to severe palmoplantar psoriasis; study completed with…
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris [Phase 2]
Phase 2 trial of LEO 32731 for moderate to severe psoriasis vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Vasoconstriction Trial With LEO 90100 Aerosol Foam [Phase 1]
The document reports the completion of a Phase 1 trial evaluating LEO 90100 aerosol foam for psoriasis vulgaris.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: LEO 32731 - A Phase I Study in Healthy Subjects [Phase 1]
This update reports the completion of a Phase I study of LEO 32731 in healthy subjects, with psoriasis vulgaris listed as the study conditio…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: A Phase I Study With LEO 32731 and Midazolam in Healthy Male Subjects [Phase 1]
A Phase 1 trial evaluating LEO 32731 with midazolam in healthy male subjects was terminated.
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris [Phase 2]
A Phase 2 psoriasis plaque test trial comparing LEO 90100 to Betesil in psoriasis vulgaris, with results posted in 2017.